8 results
PRER14A
CBAY
Cymabay Therapeutics Inc
5 May 20
Preliminary revised proxy
4:25pm
as his extensive corporate governance and board oversight experience, we believe he is able to make valuable contributions to the Board.
Kurt von … as a portfolio manager and investor, as well as his extensive corporate governance and board oversight experience, we believe he is able to make valuable
10-K/A
hbf1q0mzn78vd3v
29 Apr 20
Annual report (amended)
12:00am
PREC14A
hake5r8
27 Apr 20
Preliminary proxy with contested solicitation
4:42pm
- Prev
- 1
- Next